Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis -: An economic evaluation

被引:95
|
作者
van den Belt, AGM
Bossuyt, PMM
Prins, MH
Gallus, AS
Büller, HR
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1100 DE Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Ctr Haemostas Thrombos Atheroscler & Inflamm Res, NL-1100 DE Amsterdam, Netherlands
[3] Flinders Med Ctr, Adelaide, SA, Australia
关键词
D O I
10.1055/s-0037-1614975
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two clinical trials in patients with acute deep venous thrombosis have indicated that the outpatient management with fixed-dose, subcutaneous low-molecular-weight heparin is at least as effective and safe as inpatient treatment with unfractionated intravenous heparin with respect to recurrent venous thromboembolism and major bleeding. We performed an economic evaluation alongside one of these trials to assess the cost consequences of the outpatient management strategy. Data were collected through case record forms, complemented by a prospective questionnaire in 78 consecutive patients, interviews with health care providers, and hospital data bases. Our study demonstrated that seventy-five percent of patients allocated to low-molecular-weight heparin received treatment either entirely al home or after a brief hospital stay. Fifteen percent of these patients required professional domiciliary care. Within-centre comparisons of resource utilisation in terms of natural units showed that outpatient management with low-molecular-weight heparin reduced the average number of hospital days in the initial treatment period in nine centres by 59 percent (95% CI: 43 to 71 percent) accompanied by a limited increase in outpatient and professional domiciliary care. The average reduction in hospital days at the end of follow up was 40 percent (95% CI: 25 to 54 percent). A cost-minimisation analysis, focusing on resource utilisation directly related to the treatment of deep venous thrombosis and associated costs in one centre demonstrated a cost reduction of 64 percent (95% CI: 56 to 72 percent) with the outpatient management with low-molecular-weight heparin. These data suggest that outpatient management of patients with proximal venous thrombosis using low-molecular-weight heparin reduces resource utilisation and total treatment cost. Implementation should be preceded by a cautious evaluation of a potential cost shifting and organisational prerequisites.
引用
收藏
页码:259 / 263
页数:5
相关论文
共 50 条
  • [21] DIAGNOSIS OF DEEP VENOUS THROMBOSIS IN THE OUTPATIENT BY VENOGRAPHY
    ODONNELL, TF
    ABBOTT, WM
    ATHANASOULIS, CA
    MILLAN, VG
    CALLOW, AD
    [J]. SURGERY GYNECOLOGY & OBSTETRICS, 1980, 150 (01): : 69 - 74
  • [22] An economic evaluation of inpatient treatment versus day hospital care for psychiatric patients
    O'Shea, E
    Hughes, J
    Fitzpatrick, L
    Dunne, E
    O'Sullivan, M
    Cole, M
    [J]. IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE, 1998, 15 (04) : 127 - 130
  • [23] SUBSTITUTION OF OUTPATIENT CARE FOR INPATIENT CARE - PROBLEMS AND EXPERIENCE
    FREIBERG, L
    [J]. JOURNAL OF HEALTH POLITICS POLICY AND LAW, 1979, 3 (04) : 479 - 496
  • [24] Hospitalists And Care Transitions: The Divorce Of Inpatient And Outpatient Care
    Pham, Hoangmai H.
    Grossman, Joy M.
    Cohen, Genna
    Bodenheimer, Thomas
    [J]. HEALTH AFFAIRS, 2008, 27 (05) : 1315 - 1327
  • [25] Excess long-term mortality in outpatient deep venous thrombosis patients managed in an ambulatory care setting
    Ang, Daniel T. Y.
    Simpson, Johanne M.
    Stewart, Isaiah C.
    Murchison, John T.
    Lockman, Khalida A.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2017, 110 (03) : 149 - 153
  • [26] Outpatient operations and procedures replacing inpatient care according to 115b SGB V
    Roeder, N
    Bunzemeier, H
    Rochell, B
    Hensen, P
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2004, 42 (08): : 775 - 784
  • [27] CONTINUUM OF CARE: A DESIGNATED OUTPATIENT TREATMENT ROOM IN AN INPATIENT SETTING
    DiBenedetto, Megan
    Rodriguez, Kirby
    O'Neill, Morgan
    Sun, Michelle
    Easter, Tara
    Petigny, Sandra
    [J]. ONCOLOGY NURSING FORUM, 2023, 50 (02)
  • [28] Deep vein thrombosis in a Medicare managed care population: Prevalence and opportunity for outpatient treatment.
    Coughlin, CM
    Nelson, MA
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (04) : S219 - S219
  • [29] Evaluation of Treatment Activity in Patients With Deep Venous Thrombosis
    Gur, Ozcan
    Gurkan, Selami
    Cakir, Habib
    Gur, Demet Ozkaramanli
    Donbaloglu, Okan
    Ege, Turan
    [J]. CUKUROVA MEDICAL JOURNAL, 2012, 37 (04): : 198 - 202
  • [30] Deep venous thrombosis: clinically silent in the intensive care unit
    Crowther, MA
    Cook, DJ
    Griffith, LE
    Devereaux, PJ
    Rabbat, CG
    Clarke, FJ
    Hoad, N
    McDonald, E
    Meade, MO
    Guyatt, GH
    Geerts, WH
    Wells, PS
    [J]. JOURNAL OF CRITICAL CARE, 2005, 20 (04) : 334 - 340